TECX - Tectonic Therapeutic, Inc. News

Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight an

Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the ana

Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights

Enrollment completed in TX45 APEX Phase 2 clinical trial in patients with pulmonary hypertension ass

Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients

APEX 24-week Phase 2 trial is evaluating the safety and efficacy of TX45 in patients with pulmonary

Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform

Tectonic Therapeutic Q1 EPS $(1.34) Misses $(1.18) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.34) per share which missed the a

Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights

WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tecto

Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors

WATERTOWN, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tec

Tectonic Therapeutic: A $1B+ Opportunity Hinges On Upcoming Phase 2

Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension

Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $81.50 Consensus Price Target from Analysts

Shares of Tectonic Therapeutic, Inc. (NASDAQ: TECX - Get Free Report) have received a consensus rati

Aberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECX

Aberdeen Group plc boosted its holdings in shares of Tectonic Therapeutic, Inc. (NASDAQ: TECX) by 22

Tectonic Therapeutic, Inc. $TECX Shares Sold by Ally Bridge Group NY LLC

Ally Bridge Group NY LLC lowered its stake in shares of Tectonic Therapeutic, Inc. (NASDAQ: TECX) by

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of “Moderate Buy” from Brok

Tectonic Therapeutic, Inc. (NASDAQ: TECX - Get Free Report) has been given a consensus rating of "Mo

Tectonic Therapeutic, Inc. (TECX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

12 Health Care Stocks Moving In Friday's Pre-Market Session

Tectonic Therapeutic Q4 EPS $(1.03) Beats $(1.10) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.03) per share which beat the ana

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Busine

WATERTOWN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tect

Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tect

Here's How Much You Would Have Made Owning Tectonic Therapeutic Stock In The Last 5 Years

Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Tr

WATERTOWN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tect

12 Health Care Stocks Moving In Tuesday's Intraday Session

Goodyear Tire Posts Downbeat Earnings, Joins BP, ON Semiconductor And Other Big Stocks Moving Lower

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarke

Tiziana Life Sciences (NASDAQ:TLSA) vs. Tectonic Therapeutic (NASDAQ:TECX) Financial Comparison

Tiziana Life Sciences (NASDAQ: TLSA - Get Free Report) and Tectonic Therapeutic (NASDAQ: TECX - Get

12 Health Care Stocks Moving In Tuesday's After-Market Session

Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $82.17 Average Target Price from Brokerages

Shares of Tectonic Therapeutic, Inc. (NASDAQ: TECX - Get Free Report) have received an average ratin

Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point

Tectonic Therapeutic, Inc. achieved positive results from Part B of the phase 1b study targeting pul

Tectonic Therapeutic Q3 EPS $(1.02) Beats $(1.05) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.02) per share which beat the ana

12 Health Care Stocks Moving In Thursday's Intraday Session

Tectonic Therapeutic, Inc. (TECX) Discusses Positive Topline Results From Phase Ib Part B Trial of T

Tectonic Therapeutic, Inc. ( TECX ) Discusses Positive Topline Results From Phase Ib Part B Trial of

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in

WATERTOWN, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tect

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Targe

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Tectonic Therapeutic to Participate in September Investor Conferences

WATERTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tect

12 Health Care Stocks Moving In Thursday's After-Market Session

Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target

Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX)

Raymond James Reinstates Outperform on Tectonic Therapeutic, Announces $76 Price Target

Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outper

Reported Saturday, Tectonic Therapeutic Presents Full Phase 1b Results For TX45 in PH-HFpEF Showing

Data confirmed TX45's tolerability profile and improvements in left ventricular function and pul

Mizuho Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $85

Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises t

Tectonic Therapeutic Q1 EPS $(0.93) Beats $(1.22) Estimate

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the ana